Increasing numbers of pharmaceutical companies are cutting costs by selling properties and leasing them back off the new owners, according …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

